CONSERVATIVE
New Forest East

HEALTH – FEMALE SURGICAL MESH TREATMENT (11) [83223] - 29 November 2021

HEALTH – FEMALE SURGICAL MESH TREATMENT (11) [83223] - 29 November 2021

Dr Julian Lewis: To ask the Secretary of State for Health and Social Care, if he will establish permanent arrangements to gather testimony from members of the public with adverse experience of implanted materials, including (a) vaginal and (b) other mesh implants, and (c) silicone in (i) breast implants and (ii) contraceptive devices, in order that the long-term consequences of the use of such substances can be monitored continuously.  [83223]

[Due for Answer on 2 December. Answered on 16 December.] 

HOLDING ANSWER: The Department of Health and Social Care has indicated that it will not be possible to answer this question within the usual time period. An answer is being prepared and will be provided as soon as it is available. 

ANSWER 

The Parliamentary Under-Secretary of State for Patient Safety and Primary Care (Maria Caulfield): We have no plans to do so. The report of the Independent Medicines and Medical Devices Safety Review was published in July 2020 and investigated the impacts of three harmful medical interventions, including vaginal mesh implants. This independent report gathered testimonies from members of the public with adverse experience of mesh implants.

The Government’s response set out the actions we are taking to implement the recommendations and improve patient safety. A patient reference group was established on a temporary basis to inform the development of the Government’s full response to the Review? Anyone with safety concerns, including adverse incidents involving medical devices, can report these to a relevant medical professional and via the Medicines and Healthcare products Regulatory Agency’s Yellow Card scheme.